Amylin Pharmaceuticals - Bio, News, Photos - Washington Times
Skip to content

Topic - Amylin Pharmaceuticals

Amylin Pharmaceuticals is a biopharmaceutical company based in San Diego, CA, that was founded in 1987. The company is engaged in the discovery, development and commercialization of drug candidates for the treatment of diabetes, obesity and other diseases. Currently, Amylin produces three drugs, Symlin (pramlintide acetate) and Byetta (exenatide) and Bydureon (exenatide extended-release). Amylin also is working on producing analog of human leptin, metreleptin. - Source: Wikipedia

Related Stories

No Stories Found